Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT1B/1D receptors and α2‐adrenoceptors
Open Access
- 1 February 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (3), 585-594
- https://doi.org/10.1038/sj.bjp.0702324
Abstract
The antimigraine drugs methysergide, ergotamine and dihydroergotamine (DHE) produce selective vasoconstriction in the external carotid bed of vagosympathectomized dogs anaesthetized with pentobarbital and artificially respired, but the receptors involved have not yet been completely characterized. Since the above drugs display affinity for several binding sites, including alpha-adrenoceptors and several 5-HT1 and 5-HT2 receptor subtypes, this study has analysed the mechanisms involved in the above responses. Intracarotid (i.c.) infusions during 1 min of methysergide (31-310 microg min(-1)), ergotamine (0.56-5.6 microg min(-1)) or DHE (5.6-31 microg min(-1)) dose-dependently reduced external carotid blood flow (ECBF) by up to 46+/-4, 37+/-4 and 49+/-5%, respectively. Blood pressure and heart rate remained unchanged. The reductions in ECBF by methysergide were abolished and even reversed to increases in animals pre-treated with GR127935 (10 microg kg(-1), i.v.). The reductions in ECBF by ergotamine and DHE remained unchanged in animals pre-treated (i.v.) with prazosin (300 microg kg(-1)), but were partly antagonized in animals pre-treated with either GR127935 (10 or 30 microg kg(-1)) or yohimbine (1000 microg kg(-1)). Pre-treatment with a combination of GR127935 (30 microg kg(-1)) and yohimbine (1000 microg kg(-1)) abolished the responses to both ergotamine and DHE. The above doses of antagonists were shown to produce selective antagonism at their respective receptors. These results suggest that the external carotid vasoconstrictor responses to methysergide primarily involve 5-HT1B/1D receptors, whereas those to ergotamine and DHE are mediated by 5-HT1B/1D receptors as well as alpha2-adrenoceptors.Keywords
This publication has 50 references indexed in Scilit:
- Characterization of 5‐HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5‐HT1B/1D and novel receptorsBritish Journal of Pharmacology, 1998
- Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineLife Sciences, 1997
- Characterization of putative 5‐HT7 receptors mediating tachycardia in the catBritish Journal of Pharmacology, 1997
- Mediation of 5‐HT‐induced external carotid vasodilatation in GR 127935‐pretreated vagosympathectomized dogs by the putative 5‐HT7 receptorBritish Journal of Pharmacology, 1997
- Pharmacological Properties of a Putative 5‐HT1B/D Receptor Antagonist GR 127,935CNS Drug Reviews, 1996
- Role of α1-adrenoceptors in the reduction of external carotid blood flow induced by buspirone and ipsapirone in the dogLife Sciences, 1995
- Effects of S9977 and dihydroergotamine in an animal experimental model for migrainePharmacological Research, 1992
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Ergotamine-Induced Constriction of Cranial Arteriovenous Anastomoses in Dogs Pretreated with Phentolamine and PizotifenCephalalgia, 1983
- ROLE OF SOME BIOGENIC SUBSTANCES IN MIGRAINE AND RELEVANT MECHANISM IN ANTIMIGRAINE ACTION OF ERGOTAMINE‐STUDIES IN AN EXPERIMENTAL MODEL FOR MIGRAINEHeadache: The Journal of Head and Face Pain, 1974